Adage Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.3M | Sell |
|
|||||
|
2025
Q1 | $237M | Buy |
|
|||||
|
2024
Q4 | $84.3M | Sell |
|
|||||
|
2024
Q3 | $161M | Buy |
|
|||||
|
2024
Q2 | $157M | Sell |
|
|||||
|
2024
Q1 | $146M | Buy |
|
|||||
|
2023
Q4 | $122M | Buy |
|
|||||
|
2023
Q3 | $104M | Sell |
|
|||||
|
2023
Q2 | $108M | Sell |
|
|||||
|
2023
Q1 | $107M | Buy |
|
|||||
|
2022
Q4 | $51.9M | Sell |
|
|||||
|
2022
Q3 | $97.6M | Sell |
|
|||||
|
2022
Q2 | $161M | Sell |
|
|||||
|
2022
Q1 | $207M | Buy |
|
|||||
|
2021
Q4 | $48.5M | Buy |
|
|||||
|
2021
Q3 | $31.6M | Sell |
|
|||||
|
2021
Q2 | $68.3M | Sell |
|
|||||
|
2021
Q1 | $191M | Buy |
|
|||||
|
2020
Q4 | $161M | Buy |
|
|||||
|
2020
Q3 | $79.2M | Sell |
|
|||||
|
2020
Q2 | $116M | Sell |
|
|||||
|
2020
Q1 | $217M | Buy |
|
|||||
|
2019
Q4 | $177M | Sell |
|
|||||
|
2019
Q3 | $148M | Buy |
|
|||||
|
2019
Q2 | $120M | Buy |
|
|||||
|
2019
Q1 | $81.7M | Buy |
|
|||||
|
2018
Q4 | $71.7M | Buy |
|
|||||
|
2018
Q3 | $76.3M | Sell |
|
|||||
|
2018
Q2 | $146M | Buy |
|
|||||
|
2018
Q1 | $108M | Sell |
|
|||||
|
2017
Q4 | $204M | Buy |
|
|||||
|
2017
Q3 | $158M | Buy |
|
|||||
|
2017
Q2 | $124M | Buy |
|
|||||
|
2017
Q1 | $39.9M | Buy |
|
|||||
|
2016
Q4 | $18.7M | Sell |
|
|||||
|
2016
Q3 | $50.2M | Sell |
|
|||||
|
2016
Q2 | $59.9M | Sell |
|
|||||
|
2016
Q1 | $81.3M | Sell |
|
|||||
|
2015
Q4 | $178M | Buy |
|
|||||
|
2015
Q3 | $93.6M | Sell |
|
|||||
|
2015
Q2 | $112M | Sell |
|
|||||
|
2015
Q1 | $169M | Sell |
|
|||||
|
2014
Q4 | $249M | Sell |
|
|||||
|
2014
Q3 | $291M | Sell |
|
|||||
|
2014
Q2 | $281M | Buy |
|
|||||
|
2014
Q1 | $117M | Sell |
|
|||||
|
2013
Q4 | $283M | Buy |
|
|||||
|
2013
Q3 | $217M | Sell |
|
|||||
|
2013
Q2 | $246M | Buy |
|